Literature DB >> 9324482

[Extracorporeal shockwave therapy in orthopedics. Positive results in tennis elbow and tendinosis calcarea of the shoulder].

J D Rompe1, P Eysel, C Hopf, O Krischek, J Vogel, R Bürger, J Jage, J Heine.   

Abstract

Since the beginning of the 1990s scientific investigations on the use of extracorporeal shock wave therapy (ESWT) in the field of orthopedics have been carried out at the Orthopedic Department of the University of Mainz. Prospective studies demonstrated beneficial effects in chronic lateral humeral epicondylitis (tennis elbow), and in calcifying tendinitis of the shoulder in more than 50% of the cases. Additional indications for which positive results of prospective studies have been published during the past 2 years are plantar calcaneodynea and pseudoarthrosis. On the basis of the results achieved, it may be concluded that, for specific indications, extracorporeal shock wave therapy may now be taken out of the clinical testing stage and introduced into routine practice.

Entities:  

Mesh:

Year:  1997        PMID: 9324482

Source DB:  PubMed          Journal:  Fortschr Med        ISSN: 0015-8178


  4 in total

Review 1.  Shock wave therapy for lateral elbow pain.

Authors:  R Buchbinder; S E Green; J M Youd; W J J Assendelft; L Barnsley; N Smidt
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

Review 2.  Extracorporeal shockwave therapy in musculoskeletal disorders.

Authors:  Ching-Jen Wang
Journal:  J Orthop Surg Res       Date:  2012-03-20       Impact factor: 2.359

3.  Shock wave therapy for rotator cuff disease with or without calcification.

Authors:  Stephen J Surace; Jessica Deitch; Renea V Johnston; Rachelle Buchbinder
Journal:  Cochrane Database Syst Rev       Date:  2020-03-04

Review 4.  Efficacy and safety of extracorporeal shock wave therapy for orthopedic conditions: a systematic review on studies listed in the PEDro database.

Authors:  Christoph Schmitz; Nikolaus B M Császár; Stefan Milz; Matthias Schieker; Nicola Maffulli; Jan-Dirk Rompe; John P Furia
Journal:  Br Med Bull       Date:  2015-11-18       Impact factor: 4.291

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.